Bioatla IncNASDAQ:BCAB
- LAST PRICE1.7700
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots1.6000/ 6
- Ask / Lots2.0700/ 8
- Open / Previous Close1.7700 / 1.7700
- Day Range
- 52 Week Range
- Volume592,176
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | BCAB |
|---|---|---|
| 09:32 ET | 1530 | 1.77 |
| 09:33 ET | 3011 | 1.725 |
| 09:35 ET | 1642 | 1.7204 |
| 09:37 ET | 2957 | 1.73 |
| 09:39 ET | 3014 | 1.7 |
| 09:42 ET | 288 | 1.7 |
| 09:44 ET | 2700 | 1.6894 |
| 09:46 ET | 11715 | 1.67 |
| 09:48 ET | 1984 | 1.68 |
| 09:50 ET | 1978 | 1.7 |
| 09:51 ET | 545 | 1.67 |
| 09:53 ET | 1098 | 1.665 |
| 09:55 ET | 600 | 1.6722 |
| 09:57 ET | 11569 | 1.69 |
| 10:00 ET | 1145 | 1.7 |
| 10:02 ET | 10700 | 1.6841 |
| 10:04 ET | 8433 | 1.7 |
| 10:06 ET | 22124 | 1.72 |
| 10:08 ET | 805 | 1.715 |
| 10:09 ET | 2456 | 1.71 |
| 10:11 ET | 4551 | 1.71 |
| 10:13 ET | 5599 | 1.7001 |
| 10:15 ET | 26370 | 1.71 |
| 10:18 ET | 1517 | 1.71 |
| 10:20 ET | 300 | 1.72 |
| 10:22 ET | 6515 | 1.72 |
| 10:24 ET | 300 | 1.725 |
| 10:26 ET | 1500 | 1.73 |
| 10:27 ET | 600 | 1.74 |
| 10:29 ET | 100 | 1.735 |
| 10:31 ET | 2788 | 1.73 |
| 10:38 ET | 1000 | 1.74 |
| 10:40 ET | 27350 | 1.695 |
| 10:42 ET | 509 | 1.7 |
| 10:44 ET | 28332 | 1.71 |
| 10:47 ET | 12850 | 1.7 |
| 10:49 ET | 600 | 1.7 |
| 10:51 ET | 600 | 1.71 |
| 10:54 ET | 17153 | 1.695 |
| 10:56 ET | 1780 | 1.7 |
| 11:00 ET | 600 | 1.7095 |
| 11:03 ET | 100 | 1.705 |
| 11:05 ET | 600 | 1.7 |
| 11:07 ET | 797 | 1.7 |
| 11:09 ET | 1250 | 1.71 |
| 11:12 ET | 6433 | 1.71 |
| 11:16 ET | 6076 | 1.7 |
| 11:18 ET | 100 | 1.71 |
| 11:20 ET | 200 | 1.71 |
| 11:21 ET | 400 | 1.71 |
| 11:23 ET | 170 | 1.7099 |
| 11:25 ET | 11838 | 1.73 |
| 11:27 ET | 1531 | 1.739 |
| 11:38 ET | 222 | 1.735 |
| 11:39 ET | 5583 | 1.72 |
| 11:43 ET | 2571 | 1.74 |
| 11:45 ET | 9536 | 1.7499 |
| 11:48 ET | 5086 | 1.75 |
| 11:50 ET | 500 | 1.7487 |
| 11:54 ET | 200 | 1.75 |
| 11:56 ET | 200 | 1.76 |
| 11:57 ET | 300 | 1.7594 |
| 11:59 ET | 6540 | 1.78 |
| 12:01 ET | 13647 | 1.8 |
| 12:03 ET | 5141 | 1.8 |
| 12:06 ET | 11229 | 1.8 |
| 12:08 ET | 2961 | 1.805 |
| 12:10 ET | 2500 | 1.8025 |
| 12:12 ET | 414 | 1.8 |
| 12:14 ET | 8949 | 1.82 |
| 12:17 ET | 1005 | 1.83 |
| 12:19 ET | 800 | 1.83 |
| 12:21 ET | 705 | 1.83 |
| 12:24 ET | 5485 | 1.8 |
| 12:28 ET | 800 | 1.815 |
| 12:30 ET | 600 | 1.82 |
| 12:32 ET | 700 | 1.82 |
| 12:33 ET | 3022 | 1.82 |
| 12:35 ET | 400 | 1.82 |
| 12:37 ET | 1532 | 1.82 |
| 12:39 ET | 600 | 1.82 |
| 12:42 ET | 500 | 1.82 |
| 12:44 ET | 800 | 1.82 |
| 12:46 ET | 400 | 1.82 |
| 12:48 ET | 5500 | 1.82 |
| 12:50 ET | 3208 | 1.84 |
| 12:51 ET | 700 | 1.84 |
| 12:53 ET | 600 | 1.84 |
| 12:55 ET | 900 | 1.8425 |
| 12:57 ET | 1129 | 1.85 |
| 01:00 ET | 1540 | 1.85 |
| 01:02 ET | 3795 | 1.84 |
| 01:04 ET | 600 | 1.85 |
| 01:06 ET | 600 | 1.85 |
| 01:08 ET | 1003 | 1.84 |
| 01:09 ET | 716 | 1.845 |
| 01:11 ET | 972 | 1.83 |
| 01:13 ET | 1803 | 1.82 |
| 01:18 ET | 800 | 1.815 |
| 01:20 ET | 800 | 1.8125 |
| 01:22 ET | 3700 | 1.81 |
| 01:26 ET | 100 | 1.81 |
| 01:27 ET | 1625 | 1.8125 |
| 01:29 ET | 1669 | 1.8062 |
| 01:31 ET | 700 | 1.81 |
| 01:33 ET | 500 | 1.81 |
| 01:36 ET | 905 | 1.8125 |
| 01:38 ET | 500 | 1.82 |
| 01:40 ET | 500 | 1.82 |
| 01:42 ET | 10817 | 1.8 |
| 01:44 ET | 5000 | 1.7915 |
| 01:45 ET | 5458 | 1.79 |
| 01:49 ET | 546 | 1.8 |
| 01:51 ET | 2942 | 1.82 |
| 01:54 ET | 5093 | 1.8 |
| 01:56 ET | 1423 | 1.8001 |
| 02:05 ET | 2500 | 1.78 |
| 02:07 ET | 2791 | 1.78 |
| 02:16 ET | 2929 | 1.76 |
| 02:18 ET | 2939 | 1.75 |
| 02:23 ET | 5940 | 1.77 |
| 02:34 ET | 1000 | 1.77 |
| 02:36 ET | 133 | 1.77 |
| 02:38 ET | 564 | 1.765 |
| 02:39 ET | 1200 | 1.7693 |
| 02:41 ET | 1230 | 1.77 |
| 02:43 ET | 100 | 1.77 |
| 02:45 ET | 100 | 1.765 |
| 02:48 ET | 300 | 1.77 |
| 02:57 ET | 4000 | 1.765 |
| 03:01 ET | 400 | 1.77 |
| 03:06 ET | 383 | 1.775 |
| 03:12 ET | 314 | 1.77 |
| 03:15 ET | 100 | 1.78 |
| 03:19 ET | 100 | 1.78 |
| 03:21 ET | 100 | 1.78 |
| 03:26 ET | 2000 | 1.7879 |
| 03:28 ET | 100 | 1.785 |
| 03:30 ET | 2992 | 1.795 |
| 03:32 ET | 200 | 1.795 |
| 03:33 ET | 24861 | 1.77 |
| 03:35 ET | 1645 | 1.77 |
| 03:37 ET | 100 | 1.775 |
| 03:39 ET | 1200 | 1.765 |
| 03:44 ET | 2686 | 1.77 |
| 03:46 ET | 1400 | 1.77 |
| 03:48 ET | 800 | 1.77 |
| 03:50 ET | 900 | 1.77 |
| 03:51 ET | 6729 | 1.755 |
| 03:53 ET | 1902 | 1.75 |
| 03:55 ET | 7030 | 1.76 |
| 03:57 ET | 5043 | 1.77 |
| 04:00 ET | 2606 | 1.77 |
Nov 30, 2023
BioAtla to Participate in the JMP Securities Hematology and Oncology Summit, from 8:00AM ET on Thursday Nov 30, 2023 by Dow Jones
8:00AM ET on Thursday Nov 30, 2023 by Dow Jones
Nov 28, 2023
BioAtla to Host Virtual KOL Event to Review IASLC Data on BA3011 in NSCLC, from 8:00AM ET on Tuesday Nov 28, 2023 by Dow Jones
8:00AM ET on Tuesday Nov 28, 2023 by Dow Jones
Nov 8, 2023
DJ BioAtla Is Maintained at Buy by HC Wainwright & Co., from 8:21AM ET on Wednesday Nov 08, 2023 by Dow Jones
8:21AM ET on Wednesday Nov 08, 2023 by Dow Jones
Nov 7, 2023
BioAtla Reports Third Quarter 2023 Financial Results and Highlights Recent Progress, from 4:01PM ET on Tuesday Nov 07, 2023 by Dow Jones
4:01PM ET on Tuesday Nov 07, 2023 by Dow JonesPress Release: BioAtla Reports Third Quarter 2023 Financial Results and Highlights Recent Progress, from 4:01PM ET on Tuesday Nov 07, 2023 by Dow Jones
4:01PM ET on Tuesday Nov 07, 2023 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Bioatla Inc | 84.8M | -0.7x | --- |
Apollomics Inc | 84.3M | -18.7x | --- |
Rallybio Corp | 84.3M | -1.2x | --- |
Adverum Biotechnologies Inc | 83.6M | -0.7x | --- |
Nymox Pharmaceutical Corp | 86.7M | -17.3x | --- |
InflaRx NV | 79.5M | -1.8x | --- |
Company Information
BioAtla, Inc. is a clinical-stage biopharmaceutical company focused on developing antibody-based therapeutics for the treatment of solid tumor cancer. The Company’s product candidates include BA3011 (Mecbotamab vedotin), BA3021 (Ozuriftabmab vedotin), BA3071 and BA3182. Its lead product candidate, BA3011, is a conditionally active biologics (CAB) antibody-drug conjugates (ADC) that targets AXL, which is a protein kinase receptor. BA3021 is developing a CAB antibody drug conjugate directed against a receptor tyrosine kinase such as orphan receptor 2 (ROR2). BA3071 is a CAB anti-CTLA-4 antibody that is being developed as a therapeutic for multiple solid tumor indications, including renal cell carcinoma, NSCLC, small cell lung cancer, hepatocellular carcinoma, melanoma, bladder and gastric cancer, and cervical cancer. BA3182 is designed with an EpCAM binding domain and a CD3 binding domain, both binding domains with CAB activity (Dual-CAB), for the treatment of advanced adenocarcinoma.
Contact Information
- Headquarters
- 11085 Torreyana RoadSAN DIEGO, CA, United States 92121
- Phone
- 858-558-0708
- Fax
- 858-558-0701
Executives
- Chairman of the Board, Chief Executive Officer, Co-Founder
- Jay Short
- Chief Financial Officer, Senior Vice President
- Richard Waldron
- Senior Vice President - Finance, Corporate Controller, Secretary
- Christian Vasquez
- Chief Medical Officer
- Eric Sievers
- Director
- Scott Smith
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $84.8M |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 47.9M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | --- |
EPS | $-2.66 |
Book Value | $3.79 |
P/E Ratio | -0.7x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
